Postdoctoral fellowships at Oslo University Hospital
Three postdoctoral positions are open in the Experimental Cancer Immunotherapy Group lead by Johanna Olweus at Dept. of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital and K.G. Jebsen Center for Cancer Immunotherapy at the University of Oslo.
The organization and the research focus
Olweus is Head of the Dept. of Cancer Immunology at Oslo University Hospital Radiumhospitalet and is Director at the K.G. Jebsen Center for Cancer Immunotherapy at the University of Oslo (UiO), with which the postdoc positions will be affiliated, with the main location at the Oslo University Hospital Medical campus. The center partners include 5 research groups in Oslo and one group at the Netherlands Cancer Institute, which constitutes a partnering institution. Center partners have developed novel technologies to target cancer and that identify targets in the cancer cells themselves. The center PIs have demonstrated ability to bring results from basic research all the way to the patients, and have conducted successful clinical trials applying novel immunotherapy in patients with hematological malignancies. The main focus of the research group of Olweus is to couple clinical trials with penetrating mechanistic analyses to develop new strategies for cancer immunotherapy, and to overcome the major challenge of self-tolerance in cancer by the pursuit of two principally distinct approaches. These are: i) Identification and targeting of cancer-specific neo-antigens, and ii) Use of T cell-based alloreactivity to target self-antigens. The research is performed in an interdisciplinary and translational program.
Johanna Olweus, Prof., M.D., Ph.D.(Center Director, Oslo)
Karl Johan Malmberg, Prof., M.D., Ph.D. (Oslo)
Ton N. Schumacher, Prof., Ph.D. (The Netherlands Cancer Inst.)
Fridtjof Lund-Johansen, M.D., Ph.D (Oslo)
Kjetil Taskén, Prof., M.D., Ph.D. (Oslo)
Arne Kolstad, M.D., Ph.D. (Oslo)
The postdoctoral projects in the group of Center Director Olweus will involve studies to identify characteristics defining immunogenic T cell epitopes, development of new T-cell based immunotherapies and mechanistic characterization of immune responses in patients treated with new immunotherapy, depending on qualifications of the candidate. A wide spectrum of technologies will be used depending on the project (such as cell culture, flow cytometry, molecular biology, protein production and peptide characterization).
The candidate should be highly motivated and dedicated, and proficient in written and spoken English. Candidates with a PhD in immunology or cell biology or molecular biology, and a strong publication record in international, well-renowned journals in one of these areas are encouraged to apply.
A dynamic and stimulating scientific environment in a young, enthusiastic and motivated team of biologists and MDs. The Institute of Cancer Research is at the international forefront and houses top modern (2009) and excellent lab facilities with a wide range of core facilities (animal, light and electron microscopy, flow cytometry, genomics and bioinformatics, MR), with additional core facilities (mass spec etc) at the Rikshospitalet and UiO sites. We can offer a competitive salary. Oslo offers fantastic opportunities for outdoors activities, and is ranked as one of the best cities in the world to live in.
How to apply
A single pdf containing motivational letter, CV, list of publications and a list of 3 referee persons (please describe role relative to applicant) is sent to firstname.lastname@example.org. Please write “postdoc application IMMUNOTHERAPY” in the heading of the e-mail. Applicants who are considered relevant for the position may be asked to send transcripts etc at a later point.